Search

Your search keyword '"Beyene Moges"' showing total 2 results
Start Over Author "Beyene Moges" Journal emerging infectious diseases
2 results on '"Beyene Moges"'

1. Surveillance of Bacterial Meningitis, Ethiopia, 2012–2013

Author

Wude Mihret, Tsehaynesh Lema, Yared Merid, Afework Kassu, Workeabeba Abebe, Beyene Moges, Admasu Tenna, Fitsum Woldegebriel, Melaku Yidnekachew, Wondale Mekonnen, Arslan Ahmed, Lawrence Yamuah, Mezgebu Silamsaw, Beyene Petros, Jan Oksnes, Einar Rosenqvist, Samuel Ayele, Abraham Aseffa, Dominique A. Caugant, and Gunnstein Norheim

Subjects
bacterial meningitis, Neisseria meningitidis, Streptococcus pneumoniae, meningococci, pneumococci, meningococcal serogroups, Medicine, Infectious and parasitic diseases, RC109-216
Abstract

Among 139 patients with suspected bacterial meningitis in Ethiopia, 2012–2013, meningococci (19.4%) and pneumococci (12.9%) were the major disease-causing organisms. Meningococcal serogroups detected were A (n = 11), W (n = 7), C (n = 1), and X (n = 1). Affordable, multivalent meningitis vaccines for the African meningitis belt are urgently needed.

Published
2016
Full Text
View/download PDF

2. Surveillance of Bacterial Meningitis, Ethiopia, 2012-2013

Author

Tsehaynesh Lema, Wondale Mekonnen, Admasu Tenna, Arslan Ahmed, Afework Kassu, Beyene Petros, Melaku Yidnekachew, Lawrence Yamuah, Yared Merid, Jan Oksnes, Dominique A. Caugant, Mezgebu Silamsaw, Samuel Ayele, Wude Mihret, Einar Rosenqvist, Abraham Aseffa, Gunnstein Norheim, Fitsum Woldegebriel, Workeabeba Abebe, and Beyene Moges

Subjects
0301 basic medicine, Microbiology (medical), Adult, Male, Adolescent, Epidemiology, 030106 microbiology, lcsh:Medicine, Meningococcal Vaccines, Meningococcal vaccine, Meningitis, Meningococcal, Neisseria meningitidis, medicine.disease_cause, Pneumococcal Infections, Meningitis vaccines, Microbiology, lcsh:Infectious and parasitic diseases, Meningitis, Bacterial, 03 medical and health sciences, Young Adult, 0302 clinical medicine, Streptococcus pneumoniae, Medicine, Humans, lcsh:RC109-216, 030212 general & internal medicine, Child, bacteria, business.industry, Surveillance of Bacterial Meningitis, Ethiopia, 2012–2013, lcsh:R, Dispatch, meningococci, medicine.disease, Virology, meningococcal serogroups, pneumococci, Pneumococcal infections, Infectious Diseases, Child, Preschool, Bacterial meningitis, Female, Ethiopia, African meningitis belt, business, bacterial meningitis, real-time PCR
Abstract

Ethiopia has the second-largest population (≈94 million in 2013) among the meningitis belt countries of sub-Saharan Africa (1). However, during 2001–2010, a median of only 1,056 suspected meningitis cases per year (range 5–8,571/year) was reported to the World Health Organization (2). The largest meningitis epidemics occurred in 1981 (3) and 1989 (4), resulting in ≈45,000 and ≈50,000 cases, respectively. Serogroup A meningococci were the major cause of these epidemics, although serogroup C strains were also identified in 1981, 1983–84, and during outbreaks in 2000 and 2003 (5). Conjugate vaccines against Haemophilus influenzae serotype b, Streptococcus pneumoniae (pneumococcal conjugate vaccine [PCV] 10), and Neisseria meningitidis serogroup A (MenAfriVac) were introduced in 2007, 2011, and 2013–2015, respectively. Because data permitting assessment of these vaccines are limited, we implemented a surveillance study.

Published
2015

Catalog

Books, media, physical & digital resources
See catalog results